New study aims to predict who will benefit from liver cancer immunotherapy
NCT ID NCT07623265
First seen Jun 12, 2026 · Last updated Jun 18, 2026 · Updated 1 time
Summary
This study looks at ways to personalize treatment for people with liver cancer (hepatocellular carcinoma). Researchers want to find out which patients are likely to respond to immunotherapy by testing their tumor tissue and blood before treatment starts. The goal is to avoid giving ineffective treatments and their side effects to those who won't benefit. About 300 adults with suspected or confirmed liver cancer will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ Delta
RECRUITINGRoeselare, Belgium
Contact Email: •••••@•••••
Contact
-
AZ Groeninge
RECRUITINGKortrijk, Belgium
Contact Email: •••••@•••••
Contact
-
Jessa ziekenhuis
RECRUITINGHasselt, Belgium
Contact Email: •••••@•••••
Contact
-
UZA
RECRUITINGAntwerp, Belgium
Contact Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.